Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
14 participants
INTERVENTIONAL
2018-07-01
2020-10-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Lifestyle Exercise and Diet Trial (LEAD) 2.0
NCT06078748
Lifestyle for the BRAin Health - Nutrition and Exercise Training Intervention
NCT06986096
EXCEL: Exercise for Cognition and Everyday Living for Seniors With Memory Complaints
NCT00958867
Brain Power: Resistance Training and Cognitive Function
NCT00426881
Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study
NCT02726906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise plus Nutrition
6 months of supervised group exercise plus education and strategy training to alter diet to be consistent with recommendations outlined in our brain health food guide (BHFG).
Exercise plus nutrition
On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals.
Exercise
Identical exercise to the experimental plus education and passive discussion about brain health and healthy lifestyle to control for experimental group nutrition sessions.
Exercise
Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at \~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise plus nutrition
On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals.
Exercise
Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at \~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Answer Yes to both following questions:
1. Do you feel like your memory or thinking is becoming worse?
2. Does this concern you?
2. Have a delayed recall score on 1 paragraph of the Logical Memory test (Wechsler Memory Scale, maximum score 25) above the education-adjusted cut-offs:
* ≥9 for 16+ years of education;
* ≥5 for 8-15 years of education;
* ≥3 for 0-7 years of education.
3. Have a Montreal Cognitive Assessment (MoCA) total score of 20 and over (≥20/30).
4. Have a delayed recall score on the CERAD word list of 5 and over (≥5).
5. Have a global Clinical Dementia Rating score (CDR) equal to 0.5 or less (≤0.5).
* ≥2 vascular risk factors (overweight (BMI\>25), T2DM, hypercholesterolemia or hypertension),
* Consuming a poor quality diet (at least median or below on number of servings of vegetable, fruit, fish and nuts based on Canadian consumption patterns in older adults)
* Reasonably sedentary (less than 75min per week of moderate - vigorous intensity physical activity)
* Be available for the whole intervention (6 months) and a 12- month follow-up visit
* English speaking
Exclusion Criteria
* Ongoing alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures.
* Subject does not have a study partner who can provide corroborative information.
* Symptomatic stroke within the previous year.
* Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure.
* Major surgery within last 2 months.
* History of intracranial surgery
* Serious comorbid condition that, in the opinion of the study investigator, is likely to result in death within a year.
* High performance athletes
60 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunnybrook Health Sciences Centre
OTHER
Toronto Rehabilitation Institute
OTHER
The Centre for Memory and Aging
UNKNOWN
University of Waterloo
OTHER
Rotman Research Institute at Baycrest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carol Greenwood
Senior Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carol E Greenwood, PhD
Role: PRINCIPAL_INVESTIGATOR
Rotman Research Institute Baycrest Health Sciences
Nicole D Anderson, PhD
Role: PRINCIPAL_INVESTIGATOR
Rotman Research Institute Baycrest Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto Rehabilitation Institute Rumsey Centre
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Rotman Research Institute
Toronto, Ontario, Canada
Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Koblinsky ND, Anderson ND, Ajwani F, Parrott MD, Dawson D, Marzolini S, Oh P, MacIntosh B, Middleton L, Ferland G, Greenwood CE. Feasibility and preliminary efficacy of the LEAD trial: a cluster randomized controlled lifestyle intervention to improve hippocampal volume in older adults at-risk for dementia. Pilot Feasibility Stud. 2022 Feb 9;8(1):37. doi: 10.1186/s40814-022-00977-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCNA-NELT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.